GDC-2394
oral NLRP3 inhibitor predicted human dose of 500 mg QD LLE opt. and tox. mitig. from prev. clin. Cand. J. Med. Chem. Genentech, South San Francisco, CA
Molecules of the Month - October 2022
oral NLRP3 inhibitor predicted human dose of 500 mg QD LLE opt. and tox. mitig. from prev. clin. Cand. J. Med. Chem. Genentech, South San Francisco, CA
Molecules of the Month - October 2022